Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes

NCT01189422 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: teplizumab or placebo

Sponsor

MacroGenics

Collaborators

[object Object]